Clin2
NCT07281950Possibly a fitNot yet recruiting

Acoltremon eye drops for dry eye disease

Dry Eye Disease (DED)

Treatments studied

Part of Eyes & vision clinical trials.

This trial studies an FDA-approved eye drop called acoltremon for treating dry eye disease. The goal is to see how well it works in everyday life, using patient surveys to measure symptom improvement.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have had dry eye symptoms for at least 3 months.
  • Your dry eye symptoms are moderate to severe (score of 6 or higher on a standard questionnaire).
  • You have not had eye surgery in the last 3 months (or LASIK/PRK in the last year).
  • You have not used prescription dry eye drops or anti-inflammatory eye medicines in the last 30 days.
  • You are not currently using certain medications (like antihistamines) that can cause dry eye, unless on a stable dose for over 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07268599Enrolling by invitation
Acoltremon for moderate-to-severe dry eye relief

This study tests a new eye drop called Acoltremon to see if it can relieve symptoms of moderate-to-severe dry eye disease. It may be a good option if you have had dry eye for at least 6 months and use artificial tears.

Encino, California
NCT07732010Recruiting· Phase 4
Tryptophan for dry eye disease

This trial tests whether a dietary supplement called TRYPTYR can improve dry eye symptoms. You may qualify if you have moderate dry eye with certain signs, like short tear breakup time and staining on your eye surface.

New York, New York
NCT06879782Recruiting· Phase 3
Eye drops for dry eye disease: a phase 3 study

This study tests an eye drop called lifitegrast for people with dry eye disease. It looks at whether the drops can improve eye comfort, reduce dryness, and help eye surface health. You may be able to join if you have had dry eye symptoms and used artificial tears in the past month.

Beijing, Beijing Municipality
NCT07068958Not yet recruiting· Phase 2
Eye drop for dry eye symptoms

This trial tests an experimental eye drop (RCI001) to see if it's better than a placebo at relieving dry eye symptoms. It might help if you have moderate to severe dry eye and are looking for a new treatment.

NCT07503886Recruiting· Phase 2
Study of an eye drop for dry eye disease

This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.

Chandler, Arizona
NCT07676084Recruiting· Phase 4
Over-the-counter lubricating eye drops for dry eye

This study tests whether over-the-counter lubricating eye drops can improve dry eye symptoms and eye comfort. It compares the drops to no treatment to see how well they work.

Andover, Massachusetts

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.